Björkbacka H - Search Results

1

Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus.

Yao Mattisson I, Rattik S, Björkbacka H, Ljungcrantz I, Terrinoni M, Lebens M, Holmgren J, Fredrikson GN, Gullstrand B, Bengtsson AA, Nilsson J, Wigren M. Yao Mattisson I, et al. Among authors: bjorkbacka h. Vascul Pharmacol. 2021 Oct;140:106863. doi: 10.1016/j.vph.2021.106863. Epub 2021 Apr 15. Vascul Pharmacol. 2021. PMID: 33857652 Free article.

2

Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages.

Olofsson KE, Andersson L, Nilsson J, Björkbacka H. Olofsson KE, et al. Among authors: bjorkbacka h. Biochem Biophys Res Commun. 2008 May 30;370(2):348-52. doi: 10.1016/j.bbrc.2008.03.087. Epub 2008 Mar 25. Biochem Biophys Res Commun. 2008. PMID: 18371300

3

Inflammation and immunity in diabetic vascular complications.

Nilsson J, Bengtsson E, Fredrikson GN, Björkbacka H. Nilsson J, et al. Among authors: bjorkbacka h. Curr Opin Lipidol. 2008 Oct;19(5):519-24. doi: 10.1097/MOL.0b013e32830f47cd. Curr Opin Lipidol. 2008. PMID: 18769234 Review.

4

Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies.

Fredrikson GN, Björkbacka H, Söderberg I, Ljungcrantz I, Nilsson J. Fredrikson GN, et al. Among authors: bjorkbacka h. J Intern Med. 2008 Dec;264(6):563-70. doi: 10.1111/j.1365-2796.2008.01995.x. Epub 2008 Sep 6. J Intern Med. 2008. PMID: 18783480 Free article.

5

Atheroprotective effects of Alum are associated with capture of oxidized LDL antigens and activation of regulatory T cells.

Wigren M, Bengtsson D, Dunér P, Olofsson K, Björkbacka H, Bengtsson E, Fredrikson GN, Nilsson J. Wigren M, et al. Among authors: bjorkbacka h. Circ Res. 2009 Jun 19;104(12):e62-70. doi: 10.1161/CIRCRESAHA.109.196667. Epub 2009 May 28. Circ Res. 2009. PMID: 19478203

6

Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease.

Nilsson J, Fredrikson GN, Björkbacka H, Chyu KY, Shah PK. Nilsson J, et al. Among authors: bjorkbacka h. J Intern Med. 2009 Sep;266(3):221-31. doi: 10.1111/j.1365-2796.2009.02150.x. J Intern Med. 2009. PMID: 19702790 Free article. Review.

7

FcgammaRIIB inhibits the development of atherosclerosis in low-density lipoprotein receptor-deficient mice.

Zhao M, Wigren M, Dunér P, Kolbus D, Olofsson KE, Björkbacka H, Nilsson J, Fredrikson GN. Zhao M, et al. Among authors: bjorkbacka h. J Immunol. 2010 Mar 1;184(5):2253-60. doi: 10.4049/jimmunol.0902654. Epub 2010 Jan 22. J Immunol. 2010. PMID: 20097865

8

Atherosclerosis: cell biology and lipoproteins.

Wigren M, Björkbacka H. Wigren M, et al. Among authors: bjorkbacka h. Curr Opin Lipidol. 2010 Feb;21(1):97-8. doi: 10.1097/MOL.0b013e3283353891. Curr Opin Lipidol. 2010. PMID: 20101123 No abstract available.

9

Weak associations between human leucocyte antigen genotype and acute myocardial infarction.

Björkbacka H, Lavant EH, Fredrikson GN, Melander O, Berglund G, Carlson JA, Nilsson J. Björkbacka H, et al. J Intern Med. 2010 Jul;268(1):50-8. doi: 10.1111/j.1365-2796.2009.02209.x. Epub 2009 Dec 14. J Intern Med. 2010. PMID: 20141563 Free article.

10

Innate immunity in atherosclerosis.

Björkbacka H, Nilsson J. Björkbacka H, et al. J Innate Immun. 2010;2(4):305-6. doi: 10.1159/000314770. Epub 2010 May 12. J Innate Immun. 2010. PMID: 20505313 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters